Summary
Forty-six patients with gliomas were introduced after surgery into a therapeutic programme of six cycles of combination chemotherapy with VM26 and CCNU, followed by delayed irradiation six months after surgery with an average dose of 5,800 rads. After irradiation the same preradiation chemotherapy was readministered for an average of four cycles. The results were compared to those from another group of 28 patients treated only by the same chemotherapy (CRC and C groups successively).
Twelve patients (26%) died before irradiation in the CRC group, six patients (13%) had recurrences at the time of irradiation, and 28 patients (61%) had no clinical or radiological signs of recurrence at the time of irradiation. For the total of treated patients the median survival after surgery was 17 months, and 46% of the patients were surviving at 18 months. The percentage of survivors at 18 months was significantly more elevated in the group treated by combination chemotherapy and delayed irradiation than in a control group treated by the same combination chemotherapy alone. This result suggests that in approximately 50% of cases combination chemotherapy after surgery, and delayed irradiation six months after surgery, cumulated their effects on survival time.
Similar content being viewed by others
References
Buge, A., Poisson, M., Pouillart, P., La chimiothérapie séquentielle des glioblastomes. Etude de 176 cas. Rev. Neurol.134 (1978), 369–378.
Clarkson, B., Clinical applications of cell cycle kinetics. In: Handbook of experimental pharmacology, Vol. 38, pp. 156–193 (Eichler, O., Farah, A., Herken, H.,et al., eds.). Berlin-Heidelberg-New-York: Springer. 1974.
Frankel, S. A., German, W. J., Glioblastoma multiforme. Review of 219 cases with regard to natural history, pathology, diagnostic methods and treatment. J. Neurosurg.15 (1958), 498–503.
Gerstner, L., Jellinger, K., Heiss, W. D.,et al., Morphological changes in anaplasic gliomas treated with radiation and chemotherapy. Acta Neurochir. (Wien)36 (1977), 117–138.
Goldsmith, M. A., Carter, S. K., Glioblastoma multiforme. A review of therapy. Cancer Treat. Rev.1 (1974), 153–165.
Heiss, W. D., Turnheim, M., Mamoli, B., Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, Vincristine, amethopterine and procarbazine. Europ. J. Cancer11 (1978), 1191–1202.
Hildebrand, J., Brihaye, J., Chemotherapy of brain tumours. In: Advances and technical standards in neurosurgery, Vol. 5, pp. 51–91 (Krayenbühl, H., ed.). Wien-New-York: Springer. 1978.
Hoshino, T., Barker, M., Wilson, C. B.,et al., Cell kinetics of human gliomas. J. Neurosurg.37 (1972), 15–26.
Jelsma, R., Bucy, P. C., Glioblastoma multiforme. Its treatment and some factors affecting survival. Arch. Neurol.20 (1969), 161–171.
Levin, V. A., Wilson, C. B., Chemotherapy. The agents in current use. Semin. Oncol.2 (1975), 63–67.
Levin, V. A., Wilson, C. B., Correlations between experimental chemotherapy in the murine glioma and the effectiveness of clinical therapy regimen. Cancer Chemoth. Pharmacol.1 (1978), 41–48.
Marks, E. J., Mokhtar Gado, Serial computed tomography of primary brain tumours following surgery, irradiation and chemotherapy. Radiology125 (1977), 119–125.
Mealy, J., Chen, T. T., Shupe, R., Response of cultured human glioblastomas to radiation and BCNU therapy. J. Neurosurg.41 (1974), 339–349.
Poisson, M., Philippon, J., Van Effenterre, R.,et al., Cerebral pseudocysts following chemotherapy of glioblastomas. Acta Neurochir. (Wien)39 (1977), 143–149.
Posner, J. B., Shapiro, W. R., Brain tumours. Common status of treatment and its complications. Arch. Neurol.32 (1975), 781–784.
Pouillart, P., Palangie, T., Poisson, M.,et al., Treatment of adult malignant gliomas. I. Combined modality of chemotherapy. II. Modality of association of chemotherapy and radiation therapy. In:Recent results in cancer research. New York-Berlin-Heidelberg: Springer. 1979 (in press).
Reagan, T. J., Bisel, H. F., Childs, D. S.,et al., Controlled study of CCNU and radiation therapy in malignant astrocytoma. J. Neurosurg.44 (1976), 186–190.
Roth, J. G., Eldvidge, A. R., Glioblastoma multiforme. A clinical survey. J. Neurosurg.172 (1960), 736–750.
Shapiro, W. R., Ausman, J. I., The chemotherapy of brain tumours. A clinical and experimental review. In: Recent advances in neurology, pp. 150–235 (Plum, F., ed.). Philadelphia: F. A. Davis Co. 1969.
Shapiro, W. R., Posner, J. B., Corticosteroid hormones. Effects in an experimental brain tumour. Arch. Neurol.30 (1974), 217–221.
Shapiro, W. R., Young, D. F., Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch. Neurol.33 (1976), 494–500.
Taveras, J. M., Thompson, H. G., Pool, G. L., Should we treat glioblastoma multiforme. A study of survival in 425 cases. Amer. J. Roentgenol. Radium Ther. Nucl. Med.87 (1962), 473–479.
Walker, M. D., Strike, T. A., An evaluation of methyl CCNU-BCNU and radiotherapy in the treatment of malignant gliomas. Am. Assoc. Cancer Res.17 (1976), 163.
Walker, M. D., Gehan, E. A., An evaluation of BCNU and irradiation alone and in combination for the treatment of malignant gliomas. Proc. Am. Assoc. Cancer Res.13 (1972), 67.
Walker, M. D., Alexander, E., Hunt, W. E.,et al., Evaluation of BCNU and or radiotherapy in the treatment of anaplasic gliomas. A cooperative clinical trial. J. Neurosurg.49 (1978), 333–343.
Willson, N., Duffy, P. E., Morphologic changes associated with combined BCNU and radiation therapy in glioblastoma multiforme. Neurology (Minneap.)24 (1974), 465–471.
Wilson, C. B., Chemotherapy of brain tumours. In: Advances in neurology, Vol. 15, pp. 361–368 (Thompson, R. A., Green, J. R., eds.). Berlin-Heidelberg-New-York: Springer. 1976.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poisson, M., Pouillart, P., Bataini, J.P. et al. Malignant gliomas treated after surgery by combination chemotherapy and delayed irradiation. Acta neurochir 51, 15–25 (1979). https://doi.org/10.1007/BF01401791
Issue Date:
DOI: https://doi.org/10.1007/BF01401791